| Beneficial (n = 56) n (%) | Harmful (n = 7) n (%) | Neutral (n = 37) n (%) |
---|---|---|---|
Results | Â | Â | Â |
   Final results | 54 (96.4) | 6 (85.7) | 36 (97.3) |
   Interim results | 2 (3.6) | 1 (14.3) | 1 (2.7) |
   Clinical outcomes | 40 (71.4) | 7 (100) | 32** (86.5) |
   Non-clinical outcomes | 16 (28.6) | 0 (0) | 4 (10.8) |
Statistical significance | Â | Â | Â |
   Statistics reported | 24 (42.9) | 1 (14.3) | 7 (18.9) |
   Statistics not reported | 32 (57.1) | 6 (85.7) | 30 (81.1) |
Nature of results | Â | Â | Â |
   Quantitative | 31 (55.4) | 7 (100) | 13 (35.1) |
   Qualitative | 25 (44.6) | 0 (0) | 24 (64.9) |